Advertisement
Screener

Quince Therapeutics, Inc. (QNCX) ROA

Quince Therapeutics, Inc. (QNCX) ROA

  • 2026-06-30: ROA -74.58%.
  • 2026-03-31: ROA -124.09%.
  • 2025-12-31: ROA -89.80%.
  • 2025-09-30: ROA -51.85%.

Complete source-backed roa history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-74.58%
2026-03-31-124.09%
2025-12-31-89.80%
2025-09-30-51.85%
2025-06-30-41.83%
2025-03-31-56.69%
2024-12-31-49.64%
2024-09-30-42.10%
2024-06-30-39.40%
2024-03-31-19.01%
2023-12-31-18.69%
2023-09-30-32.82%
2023-06-30-34.44%
2023-03-31-45.30%
2022-12-31-49.72%
2022-09-30-63.33%
2022-06-30-70.68%
2022-03-31-76.21%
2021-12-31-67.51%
2021-09-30-59.09%
2021-06-30-53.85%
2021-03-31-47.42%
2020-12-31-40.56%
2020-09-30-33.55%
2020-06-30-26.01%
2020-03-31-20.97%
2019-12-31-29.73%
2019-09-30-21.04%
2019-06-30-14.47%
2019-03-31-20.94%
2018-12-31-17.12%

Annual ROA

DateROA
2025-12-31-89.80%
2024-12-31-49.64%
2023-12-31-18.69%
2022-12-31-49.72%
2021-12-31-67.51%
2020-12-31-40.56%
2019-12-31-29.73%
2018-12-31-17.12%

Similar stocks

Stock NameCountryMarket CapPE Ratio
CEL SCI CORP (CVM)United States$0.030B-0.81
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Scilex Holding Co (SCLX)United States$0.042B-0.14
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioCardia, Inc. (BCDA)United States$0.016B
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
LeonaBio, Inc. (LONA)United States$0.047B-0.61